The University of Rhode Island is a public land-grant research university with its main campus in Kingston, Rhode Island, United States. It is the flagship public research as well as the land-grant university of the state of Rhode Island. Its main campus is located in the village of Kingston in southern Rhode Island.

During the past decade, University of Rhode Island conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Rhode Island" #1 sponsor was "University of Rhode Island" with 11 trials, followed by "Brandeis University" with 1 trials sponsored, "Rhode Island Hospital" with 1 trials sponsored, "University of California, Los Angeles" with 1 trials sponsored and "University of North Carolina, Chapel Hill" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Rhode Island" #1 collaborator was "University of Rhode Island" with 4 trials as a collaborator, "Brown University" with 2 trials as a collaborator, "BayCare Health System" with 1 trials as a collaborator, "Comagine Health" with 1 trials as a collaborator and "East Carolina University" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University of Rhode Island" are "Alzheimer Disease" (2 trials), "Diet Modification" (2 trials), "Aging" (1 trials), "Alcohol Drinking" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "University of Rhode Island" in a lesser frequency.

Most popular intervention types in "University of Rhode Island" are "Behavioral" (11 trials), "Other" (4 trials), "Diagnostic Test" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "APOE genotyping" (1 trials), "Actigraphy" (1 trials), "Active Control Group" (1 trials), "Brief Intervention" (1 trials) and "Brief Intervention with Coaching" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Rhode Island" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Rhode Island". 1 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University of Rhode Island, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Rhode Island, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 13 trials that are defined as “Not Applicable".